Abstract
Patients who have received transplanted organs need to take lifelong immunosuppressive therapy to maintain their grafts. Non-adherence to this medication in renal transplant patients is associated with an increased risk of graft failure and a return to dialysis, as well as the need for another organ transplant. The purpose of this study was to identify the prevalence of non-adherence to immunosuppressive therapy in a group of post-renal transplant outpatients. A group of 500 post-transplant outpatients were enrolled. The Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS) was used to assess the prevalence of non-adherence in patients who were at least 1 year post transplant. Patients identified as non-adherent by the BAASIS questionnaire were asked to complete the Identifying Medication Adherence Barriers (IMAB) questionnaire to investigate further the reasons for non-adherence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
